Yersinia enterocolitica

The GI-MAP is a comprehensive stool test that utilizes qPCR technology to detect parasites, bacteria, fungi, and more, allowing practitioners to create personalized treatment protocols to address gut dysfunction.

The GI-MAP is a comprehensive stool test that utilizes qPCR technology to detect parasites, bacteria, fungi, and more, allowing practitioners to create personalized treatment protocols to address gut dysfunction. This test also includes an add-on for the leaky gut marker zonulin.

Measures antibodies against 32 different pathogens that may lead to autoimmune reactivities, including oral pathogens, gut pathogens, Mycoplasma, Chlamydia, Mycobacterium avium, Candida albicans, mycotoxin-producing molds (Aspergillus, Penicillium, Stachybotrys), EBV, CMV, HHV-6, and the agent and co-infections of Lyme disease. Detects possible associations between different bacteria, viruses, parasites, yeasts, and molds with more than 80 different autoimmune diseases due to cross-reactivity and molecular mimicry. It can also be used to monitor the effectiveness of various protocols in the management of autoimmune disorders triggered by pathogens. Developed and published by Aristo Vojdani, PhD, MSc, CLS, known as the father of functional immunology, in 2006, 2009, 2014, 2015, 2018, 2021, and 2024.

The BiomeFx examines the balance of pathogens and beneficial microbes that make up the microbiome and reports the potential functions of microbes to understand how the microbiome could impact symptoms and health concerns. It also provides nutrition, lifestyle, and supplement recommendations to improve the balance of the microbiome.

The GI-Advanced Profile is a comprehensive profile that analyzes 98 GI markers to provide a complete view of the GI microbiome and the insights needed to get patients on the road to wellness.